EHA

Interviews and expert commentary from EHA — study authors and key opinion leaders discuss the findings and their clinical implications.

Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World
Audio Journal of Oncology

Multiple Myeloma: Big Survival Gains From Novel Agents In The Real World

Big improvements in survival among patients with multiple myeloma were reported at the European Hematology Association annual congress in Barcelona by Greek researchers looking at the past decade of t

28 June 2010
0:00
Rituximab Maintenance Cuts Follicular Lymphoma Recurrence Risk In Half — Phase III PRIMA Study Results
Audio Journal of Oncology

Rituximab Maintenance Cuts Follicular Lymphoma Recurrence Risk In Half — Phase III PRIMA Study Results

Patients in the PRIMA study who had achieved remissions for their follicular lymphoma by means of immunochemotherapy had only half the risk of recurrence if they also received maintenance therapy with

28 June 2010
0:00